Sorafenib Completed Phase 1 Trials for Advanced Solid Tumors / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00788099Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas
NCT00449280Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
NCT00827177Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
NCT00861419To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
NCT01128998Sorafenib Plus S-1 in Advanced Solid Tumors